RHYTHM PHARMACEUTICALS, INC. Investment Income, Interest
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported Investment Income, Interest of $447.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2022-03-01
- RHYTHM PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2021-12-31 was $134.00K, a 23.86% decline year-over-year.
- RHYTHM PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2021-09-30 was $138.00K, a 70.39% decline year-over-year.
- RHYTHM PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2021-06-30 was $21.00K, a 97.38% decline year-over-year.
- RHYTHM PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2021-03-31 was $154.00K, a 86.44% decline year-over-year.
- RHYTHM PHARMACEUTICALS, INC. investment income, interest for fiscal 2021 was $447.00K, a 82.67% decline from fiscal 2020.
- RHYTHM PHARMACEUTICALS, INC. investment income, interest for fiscal 2020 was $2.58M, a 51.07% decline from fiscal 2019.
- RHYTHM PHARMACEUTICALS, INC. investment income, interest for fiscal 2019 was $5.27M, a 21.09% increase from fiscal 2018.
- RHYTHM PHARMACEUTICALS, INC. investment income, interest for fiscal 2018 was $4.35M, a 669.08% increase from fiscal 2017.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2021-12-31 | $134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $272.00K derived: sum of 2 quarters · filed 2022-03-01 | $293.00K derived: sum of 3 quarters · filed 2022-03-01 | $447.00K 10-K · filed 2022-03-01 |
| 2021-09-30 | $138.00K 10-Q · filed 2021-11-02 | $159.00K derived: sum of 2 quarters · filed 2021-11-02 | $313.00K 10-Q · filed 2021-11-02 | $489.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-06-30 | $21.00K 10-Q · filed 2021-08-03 | $175.00K 10-Q · filed 2021-08-03 | $351.00K derived: sum of 3 quarters · filed 2022-03-01 | $817.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-03-31 | $154.00K 10-Q · filed 2021-05-03 | $330.00K derived: sum of 2 quarters · filed 2022-03-01 | $796.00K derived: sum of 3 quarters · filed 2022-03-01 | $1.60M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-12-31 | $176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $642.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.44M derived: sum of 3 quarters · filed 2022-03-01 | $2.58M 10-K · filed 2022-03-01 |
| 2020-09-30 | $466.00K 10-Q · filed 2021-11-02 | $1.27M derived: sum of 2 quarters · filed 2021-11-02 | $2.40M 10-Q · filed 2021-11-02 | $3.67M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $801.00K 10-Q · filed 2021-08-03 | $1.94M 10-Q · filed 2021-08-03 | $3.21M derived: sum of 3 quarters · filed 2022-03-01 | $4.31M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $1.14M 10-Q · filed 2021-05-03 | $2.40M derived: sum of 2 quarters · filed 2022-03-01 | $3.51M derived: sum of 3 quarters · filed 2022-03-01 | $4.86M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.37M derived: sum of 2 quarters · filed 2022-03-01 | $3.73M derived: sum of 3 quarters · filed 2022-03-01 | $5.27M 10-K · filed 2022-03-01 |
| 2019-09-30 | $1.10M 10-Q · filed 2020-11-02 | $2.46M derived: sum of 2 quarters · filed 2020-11-02 | $4.00M 10-Q · filed 2020-11-02 | $5.65M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $1.35M 10-Q · filed 2020-08-03 | $2.90M 10-Q · filed 2020-08-03 | $4.54M derived: sum of 3 quarters · filed 2021-03-01 | $6.10M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $1.55M 10-Q · filed 2020-05-04 | $3.19M derived: sum of 2 quarters · filed 2021-03-01 | $4.75M derived: sum of 3 quarters · filed 2021-03-01 | $5.36M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $3.20M derived: sum of 2 quarters · filed 2021-03-01 | $3.81M derived: sum of 3 quarters · filed 2021-03-01 | $4.35M 10-K · filed 2021-03-01 |
| 2018-09-30 | $1.56M 10-Q · filed 2019-11-01 | $2.17M derived: sum of 2 quarters · filed 2019-11-01 | $2.71M 10-Q · filed 2019-11-01 | $3.16M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $609.00K 10-Q · filed 2019-07-29 | $1.15M 10-Q · filed 2019-07-29 | $1.60M derived: sum of 3 quarters · filed 2020-03-02 | $1.65M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $542.00K 10-Q · filed 2019-05-03 | $994.00K derived: sum of 2 quarters · filed 2020-03-02 | $1.04M derived: sum of 3 quarters · filed 2020-03-02 | $1.08M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $452.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $503.00K derived: sum of 2 quarters · filed 2020-03-02 | $537.00K derived: sum of 3 quarters · filed 2020-03-02 | $566.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | $51.00K 10-Q · filed 2018-11-09 | $85.00K derived: sum of 2 quarters · filed 2018-11-09 | $114.00K 10-Q · filed 2018-11-09 | $123.00K derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | $34.00K 10-Q · filed 2018-08-08 | $63.00K 10-Q · filed 2018-08-08 | $72.00K derived: sum of 3 quarters · filed 2019-03-08 | $82.00K derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-03-31 | $29.00K 10-Q · filed 2018-05-14 | $38.00K derived: sum of 2 quarters · filed 2019-03-08 | $48.00K derived: sum of 3 quarters · filed 2019-03-08 | |
| 2016-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $19.00K derived: sum of 2 quarters · filed 2019-03-08 | $33.00K 10-K · filed 2019-03-08 | |
| 2016-09-30 | $10.00K 10-Q · filed 2017-11-14 | $24.00K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |